Clinical Trial Services For Phase 1-3 Studies

Phase 1, 2, and 3 programs can stall due to slow site activation, limited patient access, and uneven protocol execution. Even well-run clinical research sites often face barriers that traditional clinical trial services can’t resolve, leading to delays, missed endpoints, and elevated regulatory risk. Strengthening clinical trial on-site support and patient-centric access points helps reduce these issues and keep timelines on track.

At 20/20 Onsite, our clinical research support services are tailored to each protocol. We align delivery modality, assessment schedule, and onsite oversight to your endpoints and regulatory expectations.

How the right clinical trial services speed up timelines:

• Site activation: Standardized SOPs, trained staff, and validated equipment accelerate readiness.
• Patient access: Point-of-need delivery brings assessments to patients, boosting enrollment, diversity, and retention.
• Protocol variability: Harmonized workflows and QA protect data integrity across sites.
• Operational complexity: Integrated onsite clinical trial management reduces sponsor/CRO coordination burden.

If you’re evaluating clinical research solutions choose a partner that delivers quality at speed without sacrificing compliance.

Keeping clinical trials on track with patient-centric, point-of-need clinical research solutions

20/20 Onsite delivers comprehensive clinical trial on-site support for Phase 1, Phase 2, and Phase 3 studies through our innovative mobile research model. Our clinical research support services streamline traditional fixed-location sites by bringing state-of-the-art ophthalmic assessments directly to participants, reducing administrative burden for site staff and supporting patient care wherever it’s needed.

Prescreening and Enrollment

We expand access to diverse participants through our clinical research support services and make pre-screening visits easy for patients.

Patient Retention

Remove barriers to ongoing study participation and decrease the risk of losing enrolled patients through on-site clinical trial management.

Ocular Endpoint Protection

Ensure accuracy, consistency, and regulatory confidence with expert ocular endpoint protection through specialized clinical trial support.

Phase 1

Clinical Trial Support with Rapid, Reliable Ocular Assessments

In Phase 1, speed is critical, yet protocols increasingly require specialized safety assessments— including ophthalmic exams— that can delay site readiness and limit participant throughput. Traditional clinical trial site services often struggle to mobilize quickly or support protocol-specific interventions, especially when healthy volunteers aren’t located near academic centers or established research sites. These early-phase challenges can also increase administrative burden for site staff and slow patient enrollment during study start-up.

How Our Clinical Research Support Services Help:

20/20 Onsite brings point-of-need ophthalmic exam directly to your Phase 1 unit or CRO partner site, reducing delays in site activation. Clinical professionals staff our mobile vision clinics with an average of 11+ years of ophthalmic experience, capable of executing protocol-specific assessments (e.g., visual acuity, fundus photography, OCT) with rapid deployment and standardized data capture.

Our clinical research solutions help sponsors meet aggressive timelines while ensuring that early safety signals are captured with precision through specialized Phase 1 clinical trial support.

Phase 2

Supporting Protocol Refinement with Patient-Centric Clinical Research Solutions

Phase 2 studies often suffer from protocol complexity and increased imaging demands, particularly for ophthalmic endpoints. Patient recruitment slows when eligible participants must travel to limited fixed locations for specialized assessments. This increases screen failure rates and stalls timeline projections in phase 2 clinical trials.

How Our Clinical Trial Services Help:

With full-service mobile vision units and centralized coordination, 20/20 Onsite enables protocol-required ophthalmic imaging through point-of-care clinical research, improving access, retention, and adherence. We support refined endpoint execution (e.g., slit lamp, lens exams, IOP, fundus exams) with quality-controlled data and site-agnostic deployment.

Our clinical research support services team collaborates with clinical operations to identify recruitment bottlenecks and deploy point-of-need assessments strategically to maximize enrollment efficiency without compromising data integrity.

Phase 3

Reducing Operational Complexity with Scalable Clinical Trial Services

Phase 3 trials demand scalability, consistency, and rigorous adherence to SOPs across dozens or even hundreds of sites. Coordinating ophthalmic assessments at scale becomes increasingly complex, with variability introduced through local providers, inconsistent equipment, and differing levels of expertise. These challenges can impact data management, slow down study start-up, and increase operational burden across therapeutic areas.

How Our Clinical Research Solutions Help:

20/20 Onsite scales with your phase 1, 2, or 3 clinical trials, ensuring uniform, protocol-compliant ophthalmic assessments regardless of location. Our mobile clinical trial units are equipped with standardized instrumentation and can handle complex protocols to ensure data comparability across all visits. With nationwide coverage and a robust data infrastructure, our clinical trial site services help sponsors reduce site burden, ensure audit-readiness, and protect data quality, while improving patient retention through convenient point-of-care clinical assessments.

Whether your trial spans urban hubs or underserved regions, we deliver high-quality assessments through comprehensive clinical trial services at the point of need.

Proven Results from Our Clinical Trial Services

Endpoint Expertise

100,000 Point-of-need eye exams performed.

Data Integrity

98% Data accuracy submission rate.

Patient Retention

91% Patient retention rate vs industry standard 70%.

Patient Centricity

95+ Patient Net Promotor Score vs industry average NPS of 30-50.